Screener
Dogwood Therapeutics DWTX EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Dogwood Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Dogwood Therapeutics’s 10-Q, filed May 15, 2026. Open the filing →
- Filed
- May 15, 2026, 9:20 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-061938
FAQ
- What is Dogwood Therapeutics's EPS (diluted)?
- Dogwood Therapeutics (DWTX) reported EPS (diluted) of -$0.15 in Q1 2026.
- How has Dogwood Therapeutics's EPS (diluted) changed year-over-year?
- Dogwood Therapeutics's EPS (diluted) increased by 98.2% year-over-year, from -$8.45 to -$0.15.
- What is the long-term trend for Dogwood Therapeutics's EPS (diluted)?
- Over 3 years (2021 to 2024), Dogwood Therapeutics's EPS (diluted) has grown at a 86.5% compound annual growth rate (CAGR), from -$1.92 to -$12.45.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Dogwood Therapeutics's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude